Zahnarzt Perren
  • Willkommen
  • Notfalldienst
  • Praxis
  • Angebot
  • Team
  • Über uns
  • Contact
  • Links
  • Menü Menü
DE | EN | ES | IT | FR | PL | EL | PT

17 PATIENT COUNSELING INFORMATION

Cialis > cialis tadalafil 20mg


  • Important Notes
  • How does the online consultation work?
  • PCI DSS Compliant
  • 2.2 Use with Food

In beagle dogs given tadalafil daily for 3 to 12 months, there was treatment-related non-reversible degeneration and atrophy of the seminiferous tubular epithelium in the testes in 20-100% of the dogs that resulted in a decrease in spermatogenesis in 40-75% of the dogs at doses of ≥10 mg/kg/day. Systemic exposure (based on AUC) at no-observed-adverse-effect-level (NOAEL) (10 mg/kg/day) for unbound tadalafil was similar to that expected in humans at the MRHD of 20 mg.There were no treatment-related testicular findings in rats or mice treated with doses up to 400 mg/kg/day for 2 years.13.2 Animal Toxicology and/or PharmacologyAnimal studies showed vascular inflammation in tadalafil-treated mice, rats, and dogs. In mice and rats, lymphoid necrosis and hemorrhage were seen in the spleen, thymus, and mesenteric lymph nodes at unbound tadalafil exposure of 2- to 33-fold above the human exposure (AUCs) at the MRHD of 20 mg. In dogs, an increased incidence of disseminated arteritis was observed in 1- and 6-month studies at unbound tadalafil exposure of 1- to 54-fold above the human exposure (AUC) at the MRHD of 20 mg. In a 12-month dog study, no disseminated arteritis was observed, but 2 dogs exhibited marked decreases in white blood cells (neutrophils) and moderate decreases in platelets with inflammatory signs at unbound tadalafil exposures of approximately 14- to 18-fold the human exposure at the MRHD of 20 mg.

Important Notes

The 3 primary outcome measures were the Erectile Function (EF) domain of the International Index of Erectile Function (IIEF) and Questions 2 and 3 from Sexual Encounter Profile (SEP). The IIEF is a 4-week recall questionnaire that was administered at the end of a treatment-free baseline period and subsequently at follow-up visits after randomization. The IIEF EF domain has a 30-point total score, where higher scores reflect better erectile function. SEP is a diary in which patients recorded each sexual attempt made throughout the study. SEP Question 2 asks, “Were you able to insert your penis into the partner's vagina?” SEP Question 3 asks, “Did your erection last long enough for you to have successful intercourse?” The overall percentage of successful attempts to insert the penis into the vagina (SEP2) and to maintain the erection for successful intercourse (SEP3) is derived for each patient.Results in ED Population in US Trials — The 2 primary US efficacy and safety trials included a total of 402 men with erectile dysfunction, with a mean age of 59 years (range 27 to 87 years).

Side effects and risks

The population was 78% White, 14% Black, 7% Hispanic, and 1% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (>90%) patients reported ED of at least 1-year duration. Study A was conducted primarily in academic centers. Study B was conducted primarily in community-based urology practices. In each of these 2 trials, CIALIS 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary tadalafil cialis daily efficacy variables (see Table 10).

How long does it take for Cialis to work?

The treatment effect of CIALIS did not diminish over time.Results in General ED Population in Trials Outside the US — The 5 primary efficacy and safety studies conducted in the general ED population outside the US included 1112 patients, with a mean age of 59 years (range 21 to 82 years). The population was 76% White, 1% Black, 3% Hispanic, and 20% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (90%) patients reported ED of at least 1-year duration. In these 5 trials, CIALIS 5, 10, and 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables (see Tables 11, 12 and 13). The treatment effect of CIALIS did not diminish over time.In addition, there were improvements in EF domain scores, success rates based upon SEP Questions 2 and 3, and patient-reported improvement in erections across patients with ED of all degrees of disease severity while taking CIALIS, compared to patients on placebo.Therefore, in all 7 primary efficacy and safety studies, CIALIS showed statistically significant improvement in patients' ability to achieve an erection sufficient for vaginal penetration and to maintain the erection long enough for successful intercourse, as measured by the IIEF questionnaire and by SEP diaries.Efficacy Results in ED Patients with Diabetes Mellitus — CIALIS was shown to be effective in treating ED in patients with diabetes mellitus. The abnormal blood-cell findings were reversible within 2 weeks upon removal of the drug.Reproductive Toxicology StudiesReproduction studies have been performed in rats and mice at exposures up to 11 times the maximum recommended human dose (MRHD) of 20 mg and have revealed no evidence of impaired fertility or harm to the fetus due to tadalafil. In addition, there was no evidence of teratogenicity, embryotoxicity, or fetotoxicity when tadalafil was given to pregnant rats or mice at exposures up to 11 times the MRHD during the period of major organ development.In a rat prenatal and postnatal development study at doses of 60, 200, and 1000 mg/kg, a reduction in postnatal survival of pups was observed. The no observed effect level (NOEL) for maternal toxicity was 200 mg/kg/day and for developmental toxicity was 30 mg/kg/day.

Product Dosage Quantity + Bonus Price
Cialis Original20mg64 + 4 Pills274.18€ 261.12€
Cialis Black80mg120 + 8 Pills264.77€ 252.16€
Cialis Generic5mg270 + 10 Pills205.81€ 196.01€
Cialis Professional20mg180 + 4 Pills423.11€ 402.96€
Cialis Soft Tabs20mg180 + 8 Pills353.17€ 336.35€
Cialis Generic10mg90 + 6 Pills146.17€ 139.21€
Cialis Generic20mg90 + 6 Pills154.71€ 147.34€
Cialis Generic60mg20 Pills65.61€ 62.49€
Cialis Generic20mg30 + 4 Pills68.05€ 64.81€
Cialis Soft Tabs20mg120 + 6 Pills248.64€ 236.80€
Cialis Professional20mg60 + 2 Pills183.83€ 175.08€
Cialis Generic2.5mg10 Pills28.51€ 27.15€

This gives approximately 16 and 10 fold exposure multiples, respectively, of the human AUC for the MRHD of 20 mg. Tadalafil and/or its metabolites cross the placenta, resulting in fetal exposure in rats.Tadalafil and/or its metabolites were secreted into the milk in lactating rats at concentrations approximately 2.4-fold greater than found cialis soft online in the plasma. Tadalafil was not carcinogenic to rats or mice when administered daily for 2 years at doses up to 400 mg/kg/day. Systemic drug exposures, as measured by AUC of unbound tadalafil, were approximately 10-fold for mice, and 14- and 26-fold for male and female rats, respectively, the exposures in human males given Maximum Recommended Human Dose (MRHD) of 20 mg. Tadalafil was not mutagenic in the in vitro bacterial Ames assays or the forward mutation test in mouse lymphoma cells. There were no effects on fertility, reproductive performance or reproductive organ morphology in male or female rats given oral doses of tadalafil up to 400 mg/kg/day, a dose producing AUCs for unbound tadalafil of 14-fold for males or 26-fold for females the exposures observed in human males given the MRHD of 20 mg. Systemic exposure (based on AUC) at no-observed-adverse-effect-level (NOAEL) (10 mg/kg/day) for unbound tadalafil was similar to that expected in humans at the MRHD of 20 mg. There were no treatment-related testicular findings in rats or mice treated with doses up to 400 mg/kg/day for 2 years. Animal studies showed vascular inflammation in tadalafil-treated mice, rats, and dogs. The abnormal blood-cell findings were reversible within 2 weeks upon removal of the drug. Reproduction studies have been performed in rats and mice at exposures up to 11 times the maximum recommended human dose (MRHD) of 20 mg and have revealed no evidence of impaired fertility or harm to the fetus due to tadalafil.

  • Cialis Tadalafil 20mg can be part of a comprehensive ED treatment plan.
  • Proper hydration helps reduce side effects.
  • Avoid driving if you experience dizziness.
  • Combine medication with healthy lifestyle choices.
  • Always store medication safely out of reach of children.

In addition, there was no evidence of teratogenicity, embryotoxicity, or fetotoxicity when tadalafil was given to pregnant rats or mice at exposures up to 11 times the MRHD during the period of major organ development.

Region Average Cost per 20mg Tablet Insurance Coverage Availability
United States $10-$20 Varies Widely available via pharmacies
Europe €8-€15 Generally not covered Available in OTC or prescription
Asia $2-$8 Less common Accessible at local pharmacies

In a rat prenatal and postnatal development study at doses of 60, 200, and 1000 mg/kg, a reduction in postnatal survival of pups was observed. This gives approximately 16 and 10 fold exposure multiples, respectively, of the human AUC for the cialis without a doctor prescription MRHD of 20 mg. Tadalafil and/or its metabolites cross the placenta, resulting in fetal exposure in rats. Tadalafil and/or its metabolites were secreted into the milk in lactating rats at concentrations approximately 2.4-fold greater than found in the plasma. 14 CLINICAL STUDIES 14.1 CIALIS for Use as NeededThe efficacy and safety of tadalafil in the treatment of erectile dysfunction has been evaluated in 22 clinical trials of up to 24-weeks duration, involving over 4000 patients. CIALIS, when taken as needed up to once per day, was shown to be effective in improving erectile function in men with erectile dysfunction (ED).CIALIS was studied in the general ED population in 7 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12-weeks duration.

  • Long-term studies on the safety of chronic tadalafil use are reassuring.
  • No evidence suggests it causes dependency or addiction.
  • Tolerance (needing more for the same effect) does not typically develop.
  • Some men may find they need it less as underlying health improves.
  • Discontinuation does not cause "rebound" ED worse than before.
  • If you stop, your erectile function will likely return to its baseline state.
  • It is not a hormone and does not affect testosterone production.
  • It does not shrink the testes or affect sperm production.
  • In fact, some studies suggest it may improve sperm parameters.
  • This is an area of ongoing research.
  • It is not a form of birth control.
  • Use appropriate contraception if pregnancy is not desired.

Two of these studies were conducted in the United States and 5 were conducted in centers outside the US. Additional efficacy and safety studies were performed in ED patients with diabetes mellitus and in patients who developed ED status post bilateral nerve-sparing radical prostatectomy.In these 7 trials, CIALIS was taken as needed, at doses ranging from 2.5 to 20 mg, up to once per day.

How does the online consultation work?

There were no treatment-related testicular findings in rats or mice treated with doses up to 400 mg/kg/day for 2 years. Animal studies showed vascular inflammation in tadalafil-treated mice, rats, and dogs. The abnormal blood-cell findings were reversible within 2 weeks upon removal of the drug. Reproduction studies have been performed in rats and mice at exposures up to 11 times the maximum recommended human dose (MRHD) of 20 mg and have revealed no evidence of impaired fertility or harm to the fetus due to tadalafil. In addition, there was no evidence of teratogenicity, embryotoxicity, or fetotoxicity when tadalafil was given to pregnant rats or mice at exposures up to 11 times the MRHD during the period of major organ development.

Serious side effects

In a rat prenatal and postnatal development study at doses of 60, 200, and 1000 mg/kg, a reduction in postnatal survival of pups was observed. This gives approximately 16 and 10 fold exposure multiples, respectively, of the human AUC for the cialis without a doctor prescription MRHD of 20 mg. Tadalafil and/or its metabolites cross the placenta, resulting in fetal exposure in rats. Tadalafil and/or its metabolites were secreted into the milk in lactating rats at concentrations approximately 2.4-fold greater than found in the plasma. 14 CLINICAL STUDIES 14.1 CIALIS for Use as NeededThe efficacy and safety of tadalafil in the treatment of erectile dysfunction has been evaluated in 22 clinical trials of up to 24-weeks duration, involving over 4000 patients.

Side effect details

CIALIS, when taken as needed up to once per day, was shown to be effective in improving erectile function in men with erectile dysfunction (ED).CIALIS was studied in the general ED population in 7 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12-weeks duration. Two of these studies were conducted in the United States and 5 were conducted in centers outside the US. Additional efficacy and safety studies were performed in ED patients with diabetes mellitus and in patients who developed ED status post bilateral nerve-sparing radical prostatectomy.In these 7 trials, CIALIS was taken as needed, at doses ranging from 2.5 to 20 mg, up to once per day. Patients were free to choose the time interval between dose administration and the time of sexual attempts. Food and alcohol intake were not restricted.Several assessment tools were used to evaluate the effect of CIALIS on erectile function. Patients were free to choose the time interval between dose administration and the time of sexual attempts. Food and alcohol intake were not restricted.Several assessment tools were used to evaluate the effect of CIALIS on erectile function. The 3 primary outcome measures were the Erectile Function (EF) domain of the International Index of Erectile Function (IIEF) and Questions 2 and 3 from Sexual Encounter Profile (SEP). The IIEF is a 4-week recall questionnaire that was administered at the end of a treatment-free baseline period and subsequently at follow-up visits after randomization.

PCI DSS Compliant

In beagle dogs given tadalafil daily for 3 to 12 months, there was treatment-related non-reversible degeneration and atrophy of the seminiferous tubular epithelium in the testes in 20-100% of the dogs that resulted in a decrease in spermatogenesis in 40-75% of the dogs at doses of ≥10 mg/kg/day. Systemic exposure (based on AUC) at no-observed-adverse-effect-level (NOAEL) (10 mg/kg/day) for unbound tadalafil was similar to that expected in humans at the MRHD of 20 mg.There were no treatment-related testicular findings in rats or mice treated with doses up to 400 mg/kg/day for 2 years.13.2 Animal Toxicology and/or PharmacologyAnimal studies showed vascular inflammation in tadalafil-treated mice, rats, and dogs. In mice and rats, lymphoid necrosis and hemorrhage were seen in the spleen, thymus, and mesenteric lymph nodes at unbound tadalafil exposure of 2- to 33-fold above the human exposure (AUCs) at the MRHD of 20 mg. In dogs, an increased incidence of disseminated arteritis was observed in 1- and 6-month studies at unbound tadalafil exposure of 1- to 54-fold above the human exposure (AUC) at the MRHD of 20 mg. In a 12-month dog study, no disseminated arteritis was observed, but 2 dogs exhibited marked decreases in white blood cells (neutrophils) and moderate decreases in platelets with inflammatory signs at unbound tadalafil exposures of approximately 14- to 18-fold the human exposure at the MRHD of 20 mg.

What to do in case of overdose

The abnormal blood-cell findings were reversible within 2 weeks upon removal of the drug.Reproductive Toxicology StudiesReproduction studies have been performed in rats and mice at exposures up to 11 times the maximum recommended human dose (MRHD) of 20 mg and have revealed no evidence of impaired fertility or harm to the fetus due to tadalafil. In addition, there was no evidence of teratogenicity, embryotoxicity, or fetotoxicity when tadalafil was given to pregnant rats or mice at exposures up to 11 times the MRHD during the period of major organ development.In a rat prenatal and postnatal development study at doses of 60, 200, and 1000 mg/kg, a reduction in postnatal survival of pups was observed. The no observed effect level (NOEL) for maternal toxicity was 200 mg/kg/day and for developmental toxicity was 30 mg/kg/day. This gives approximately 16 and 10 fold exposure multiples, respectively, of the human AUC for the MRHD of 20 mg. Tadalafil and/or its metabolites cross the placenta, resulting in fetal exposure in rats.Tadalafil and/or its metabolites were secreted into the milk in lactating rats at concentrations approximately 2.4-fold greater than found cialis soft online in the plasma.

Benign prostatic hyperplasia explained

Tadalafil was not carcinogenic to rats or mice when administered daily for 2 years at doses up to 400 mg/kg/day. Systemic drug exposures, as measured by AUC of unbound tadalafil, were approximately 10-fold for mice, and 14- and 26-fold for male and female rats, respectively, the exposures in human males given Maximum Recommended Human Dose (MRHD) of 20 mg. Tadalafil was not mutagenic in the in vitro bacterial Ames assays or the forward mutation test in mouse lymphoma cells. There were no effects on fertility, reproductive performance or reproductive organ morphology in male or female rats given oral doses of tadalafil up to 400 mg/kg/day, a dose producing AUCs for unbound tadalafil of 14-fold for males or 26-fold for females the exposures observed in human males given the MRHD of 20 mg. Systemic exposure (based on AUC) at no-observed-adverse-effect-level (NOAEL) (10 mg/kg/day) for unbound tadalafil was similar to that expected in humans at the MRHD of 20 mg. The IIEF EF domain has a 30-point total score, where higher scores reflect better erectile function. SEP is a diary in which patients recorded each sexual attempt made throughout the study. SEP Question 2 asks, “Were you able to insert your penis into the partner's vagina?” SEP Question 3 asks, “Did your erection last long enough for you to have successful intercourse?” The overall percentage of successful attempts to insert the penis into the vagina (SEP2) and to maintain the erection for successful intercourse (SEP3) is derived for each patient.Results in ED Population in US Trials — The 2 primary US efficacy and safety trials included a total of 402 men with erectile dysfunction, with a mean age of 59 years (range 27 to 87 years). The population was 78% White, 14% Black, 7% Hispanic, and 1% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (>90%) patients reported ED of at least 1-year duration. Study A was conducted primarily in academic centers. Study B was conducted primarily in community-based urology practices. In each of these 2 trials, CIALIS 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary tadalafil cialis daily efficacy variables (see Table 10). The treatment effect of CIALIS did not diminish over time.Results in General ED Population in Trials Outside the US — The 5 primary efficacy and safety studies conducted in the general ED population outside the US included 1112 patients, with a mean age of 59 years (range 21 to 82 years). The population was 76% White, 1% Black, 3% Hispanic, and 20% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease.

2.2 Use with Food

Patients with diabetes were included in all 7 primary efficacy studies in the general ED population (N=235) and in one study that specifically assessed CIALIS in ED patients with type 1 or type 2 diabetes (N=216). In this randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial, CIALIS demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 14).Efficacy Results in ED Patients following Radical Prostatectomy — CIALIS was shown to be effective in treating patients who developed ED following bilateral nerve-sparing radical prostatectomy. Most (90%) patients reported ED of at least 1-year duration. In these 5 trials, CIALIS 5, 10, and 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables (see Tables 11, 12 and 13).

Drug Name Active Ingredient Onset of Action Duration Common Side Effects
Cialis Tadalafil 30-60 min Up to 36 hours Headache, flushing, dyspepsia
Viagra Sildenafil 30-60 min 4-6 hours Vision changes, headache
Levitra Vardenafil 25-60 min 4-5 hours Dizziness, flushing

The treatment effect of CIALIS did not diminish over time.In addition, there were improvements in EF domain scores, success rates based upon SEP Questions 2 and 3, and patient-reported improvement in erections across patients with ED of all degrees of disease severity while taking CIALIS, compared to patients on placebo.Therefore, in all 7 primary efficacy and safety studies, CIALIS showed statistically significant improvement in patients' ability to achieve an erection sufficient for vaginal penetration and to maintain the erection long enough for successful intercourse, as measured by the IIEF questionnaire and by SEP diaries.Efficacy Results in ED Patients with Diabetes Mellitus — CIALIS was shown to be effective in treating ED in patients with diabetes mellitus. Patients with diabetes were included in all 7 primary efficacy studies in the general ED population (N=235) and in one study that specifically assessed CIALIS in ED patients with type 1 or type 2 diabetes (N=216). In this randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial, CIALIS demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 14).Efficacy Results in ED Patients following Radical Prostatectomy — CIALIS was shown to be effective in treating patients who developed ED following bilateral nerve-sparing radical prostatectomy.

  • Cialis Online in Canada: Tadalafil Prescriptions Made Simple
  • Tadalafil 5 mg
  • How to get Cialis online in Canada
  • Sildenafil and Its Effects on Uterine Blood Flow
  • The Connection Between Exercise and Female Libido
  • Tadalafil ohne Rezept kaufen
  • Cialis Φαρμακειο Θεσσαλονικη

ZurückWeiter
123

In der Zahnarztpraxis Perren an der Bahnhofstrasse 4A in Brig-Glis finden sie die optimalen Voraussetzungen für eine nachhaltige Behandlung: Unser bestens qualifiziertes Team, modernste Ausrüstung sowie die Verwendung hochwertigster Materialien garantieren Ihnen Zahnmedizin gemäss dem neuesten Stand der Technik und auf höchstem Qualitätsniveau.

© Zahnarztpraxis Perren

  • Rechtliches
  • Privacy
  • Imprint
Nach oben scrollen

Diese Website verwendet Cookies.

EinverstandenInformationen

Cookie- und Datenschutzeinstellungen



Wie wir Cookies verwenden

Wir können Cookies anfordern, die auf Ihrem Gerät eingestellt werden. Wir verwenden Cookies, um uns mitzuteilen, wenn Sie unsere Websites besuchen, wie Sie mit uns interagieren, Ihre Nutzererfahrung verbessern und Ihre Beziehung zu unserer Website anpassen.

Klicken Sie auf die verschiedenen Kategorienüberschriften, um mehr zu erfahren. Sie können auch einige Ihrer Einstellungen ändern. Beachten Sie, dass das Blockieren einiger Arten von Cookies Auswirkungen auf Ihre Erfahrung auf unseren Websites und auf die Dienste haben kann, die wir anbieten können.

Notwendige Website Cookies

Diese Cookies sind unbedingt erforderlich, um Ihnen die auf unserer Webseite verfügbaren Dienste und Funktionen zur Verfügung zu stellen.

Da diese Cookies für die auf unserer Webseite verfügbaren Dienste und Funktionen unbedingt erforderlich sind, hat die Ablehnung Auswirkungen auf die Funktionsweise unserer Webseite. Sie können Cookies jederzeit blockieren oder löschen, indem Sie Ihre Browsereinstellungen ändern und das Blockieren aller Cookies auf dieser Webseite erzwingen. Sie werden jedoch immer aufgefordert, Cookies zu akzeptieren / abzulehnen, wenn Sie unsere Website erneut besuchen.

Wir respektieren es voll und ganz, wenn Sie Cookies ablehnen möchten. Um zu vermeiden, dass Sie immer wieder nach Cookies gefragt werden, erlauben Sie uns bitte, einen Cookie für Ihre Einstellungen zu speichern. Sie können sich jederzeit abmelden oder andere Cookies zulassen, um unsere Dienste vollumfänglich nutzen zu können. Wenn Sie Cookies ablehnen, werden alle gesetzten Cookies auf unserer Domain entfernt.

Wir stellen Ihnen eine Liste der von Ihrem Computer auf unserer Domain gespeicherten Cookies zur Verfügung. Aus Sicherheitsgründen können wie Ihnen keine Cookies anzeigen, die von anderen Domains gespeichert werden. Diese können Sie in den Sicherheitseinstellungen Ihres Browsers einsehen.

Andere externe Dienste

Wir nutzen auch verschiedene externe Dienste wie Google Webfonts, Google Maps und externe Videoanbieter. Da diese Anbieter möglicherweise personenbezogene Daten von Ihnen speichern, können Sie diese hier deaktivieren. Bitte beachten Sie, dass eine Deaktivierung dieser Cookies die Funktionalität und das Aussehen unserer Webseite erheblich beeinträchtigen kann. Die Änderungen werden nach einem Neuladen der Seite wirksam.

Google Webfont Einstellungen:

Google Maps Einstellungen:

Google reCaptcha Einstellungen:

Vimeo und YouTube Einstellungen:

Datenschutzrichtlinie

Sie können unsere Cookies und Datenschutzeinstellungen im Detail in unseren Datenschutzrichtlinie nachlesen.

Privacy
Einstellungen akzeptierenVerberge nur die Benachrichtigung